Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 236,424 | 4,309 | 0 | 0 | 0 |
| Gross Profit | 236,424 | 4,309 | N/A | N/A | N/A |
| Operating Expenses | 212,582 | 214,739 | 0 | 0 | 0 |
| Operating Income | 23,842 | -210,430 | N/A | N/A | N/A |
| Interest Expense | 147 | 430 | 0 | 0 | 0 |
| Other Income | 50,349 | 2,300 | 0 | 0 | 0 |
| Pre-tax Income | 74,044 | -208,560 | 0 | 0 | 0 |
| Income Tax | 1,874 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 72,170 | -208,560 | N/A | N/A | N/A |
| Net Income | $72,170 | $-208,560 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | 1.24 | -66.47 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 1.24 | -64.99 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 1.06 | -66.47 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 1.06 | -64.99 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 1.06 | -28.90 | N/A | N/A | N/A |
| EBITDA(a) | $27,387 | $-208,184 | $N/A | $N/A | $N/A |